Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-24 @ 7:55 PM
NCT ID:
NCT00503204
Eligibility Criteria:
Inclusion Criteria:
* Primary recurrent malignant brain tumour for whom lomustine would be standard therapy - diagnosis \& stage
* Patients received no more than 2 previous systemic chemotherapy regimes
* Life Expectancy \> 12 weeks
* Patients must be at least 3 months from the completion of cranial radiation therapy
Exclusion Criteria:
* History of poorly controlled high blood pressure
* Recent major surgery prior to entry into the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00503204
Study Brief:
Protocol Section:
NCT00503204